GDP
ABBV icon

Great Diamond Partners’s AbbVie ABBV Stock Holding History

Great Diamond Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
5,368
-5,459
-50% -$1.17M 0.23% 102
2026
Q1 		$2.35M Buy
10,827
+892
+9% +$198K 0.45% 71
2025
Q4 		$2.27M Buy
9,935
+118
+1% +$26.9K 0.44% 71
2025
Q3 		$2.27M Buy
9,817
+178
+2% +$36.2K 0.44% 70
2025
Q2 		$1.79M Buy
9,639
+1,040
+12% +$193K 0.38% 75
2025
Q1 		$1.8M Sell
8,599
-60
-0.7% -$11.7K 0.49% 63
2024
Q4 		$1.54M Buy
8,659
+207
+2% +$38.1K 0.4% 70
2024
Q3 		$1.67M Sell
8,452
-1,712
-17% -$320K 0.42% 69
2024
Q2 		$1.74M Sell
10,164
-666
-6% -$110K 0.41% 69
2024
Q1 		$1.97M Buy
10,830
+1
+0% +$172 0.45% 62
2023
Q4 		$1.68M Buy
10,829
+204
+2% +$29.7K 0.41% 63
2023
Q3 		$1.58M Buy
10,625
+171
+2% +$25.1K 0.43% 61
2023
Q2 		$1.41M Sell
10,454
-482
-4% -$70.7K 0.37% 73
2023
Q1 		$1.74M Sell
10,936
-888
-8% -$136K 0.5% 50
2022
Q4 		$1.91M Buy
11,824
+304
+3% +$46.6K 0.59% 47
2022
Q3 		$1.55M Buy
11,520
+3,998
+53% +$574K 0.53% 51
2022
Q2 		$1.15M Buy
7,522
+123
+2% +$18.8K 0.38% 62
2022
Q1 		$1.2M Buy
7,399
+31
+0.4% +$4.5K 0.33% 74
2021
Q4 		$997K Buy
7,368
+641
+10% +$75.7K 0.26% 88
2021
Q3 		$725K Buy
6,727
+2,134
+46% +$244K 0.2% 99
2021
Q2 		$517K Sell
4,593
-21
-0.5% -$2.37K 0.15% 117
2021
Q1 		$499K Buy
4,614
+21
+0.5% +$2.25K 0.15% 116
2020
Q4 		$492K Sell
4,593
-50
-1% -$4.8K 0.16% 106
2020
Q3 		$406K Buy
4,643
+28
+0.6% +$2.64K 0.15% 106
2020
Q2 		$453K Buy
4,615
+22
+0.5% +$1.94K 0.19% 85
2020
Q1 		$349K Hold
4,593
– – 0.18% 83
2019
Q4 		$406K Buy
+4,593
New +$381K 0.15% 88

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Great Diamond Partners's ABBV Position: Q2 2026 in Review

Great Diamond Partners reduced its AbbVie (ABBV) stake by 50% in Q2 2026, selling an estimated $1.17M and leaving 5,368 shares worth $1.35M. The position accounts for 0.23% of the portfolio, ranked #102.

Great Diamond Partners first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.35M in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Great Diamond Partners held 5,368 shares of AbbVie worth $1.35M as of Q2 2026.
  • Great Diamond Partners sold 5,459 AbbVie shares in Q2 2026, an estimated $1.17M.
  • AbbVie made up 0.23% of Great Diamond Partners's portfolio in Q2 2026, its #102 holding.
  • Great Diamond Partners first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Great Diamond Partners's AbbVie position peaked at $2.35M in Q1 2026.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.